Michael Vajdy has been a cofounder and the CEO of EpitoGenesis Inc. since November of 2008. Dr. Vajdy is a mucosal immunologist with 20 years of experience in designing mucosal and systemic adjuvants and vaccines, studying mucosal and systemic B and T cell immune induction mechanisms and long-term immunological memory. Following Ph.D. studentship at Goteborg University under the supervision of Dr. Nils Lycke, a prominent mucosal immunologist, Dr. Vajdy completed his first postdoctoral fellowship with Dr. Katherine Knight, and then he became the President of the American Association of Immunologists. Dr. Vajdy completed his second postdoctoral fellowship with Dr. Marian Neutra, an expert in mucosal biology and M cells of the intestinal Peyer’s patches. Dr. Vajdy was recruited to Chiron Corporation, later acquired by Novartis Vaccines and Diagnostics Inc., where he remained for 9.5 years with increasing responsibilities including project leadership for a vaccine manufacturing platform technology. Moreover, he also held simultaneous academic positions as an Adjunct Clinical Assistant Professor with the Division of Infectious Diseases, Department of Internal Medicine, and as a Visiting Associate Professor at the Department of Medical Microbiology and Immunology, University of California, Davis, Calif, USA. He was also a faculty member with the Graduate Group, Department of Comparative Pathology, University of California, Davis, Calif, USA. In these capacities, he trained a Ph.D. student and 3 postdoctoral fellows and wrote collaborative NIH grants. Dr. Vajdy has authored 50 papers and book chapters. He is the Editor of a book entitled Immunity against Mucosal Pathogens (Springer, 2008).
Biography Updated on 22 November 2010